Literature DB >> 31655098

Advances in eosinophilic diseases in 2018.

Amy D Klion1, Marc E Rothenberg2.   

Abstract

Interest in eosinophil biology and eosinophilic diseases is increasing, as reflected in a doubling of the number of annual articles focused on this topic published in the Journal of Allergy and Clinical Immunology over the past decade. Although the majority of these publications relate to eosinophilic asthma, a growing proportion of them focus on breakthroughs in the diagnosis, treatment, and pathogenesis of other eosinophilic disorders, most notably eosinophilic esophagitis. This review highlights advances in our understanding of eosinophilia and eosinophilic disorders (excluding asthma) published in the Journal in 2018.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Apoptosis; asthma; eosinophils; esophagitis; gastrointestinal and hypereosinophilic

Mesh:

Year:  2019        PMID: 31655098     DOI: 10.1016/j.jaci.2019.10.010

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  3 in total

1.  Treatment of allergic eosinophilic asthma through engineered IL-5-anchored chimeric antigen receptor T cells.

Authors:  Sisi Chen; Gaoying Chen; Fang Xu; Beibei Sun; Xinyi Chen; Wei Hu; Fei Li; Madiha Zahra Syeda; Haixia Chen; Youqian Wu; Peng Wu; Ruirui Jing; Xinwei Geng; Lingling Zhang; Longguang Tang; Wen Li; Zhihua Chen; Chao Zhang; Jie Sun; Wei Chen; Huahao Shen; Songmin Ying
Journal:  Cell Discov       Date:  2022-08-16       Impact factor: 38.079

2.  Clinico-pathological characteristics of eosinophilic esophagitis in Jordanian children.

Authors:  Eyad Altamimi; Bayan Ahmad; Abdullah Abu-Aqoulah; Naif Rawabdeh
Journal:  Prz Gastroenterol       Date:  2021-10-14

3.  Leptin Elicits In Vivo Eosinophil Migration and Activation: Key Role of Mast Cell-Derived PGD2.

Authors:  Natália R T Amorim; Glaucia Souza-Almeida; Tatiana Luna-Gomes; Patricia T Bozza; Claudio Canetti; Bruno L Diaz; Clarissa M Maya-Monteiro; Christianne Bandeira-Melo
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-29       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.